JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Interleukin 3, produced by activated T cells and mast cells, induces the differentiation of hematopoietic stem cells into myeloid precursor cells, such as erythrocyte, megakaryocyte, granulocyte, monocyte, and dendritic cells. IL-3 also functions in the nervous system and during B-1 cell regulation of chronic inflammatory diseases.
This product is produced from E. coli and is manufactured in a facility that does not use or process beta-lactam containing materials. No animal- or human-derived materials were used during manufacturing or as ingredients. This product is manufactured, tested, and released in an ISO 9001:2015 certified facility and follows cGMP practices. USP chapter <1043> for ancillary materials considered in the manufacture of this product.
> 98% by reducing and non-reducing SDS-PAGE
ED50 < 2 ng/ml, determined by dose-dependent proliferation of human TF-1 cells.
~4.2 x 103 IU/µg, which is calibrated against the recombinant Human IL-3 WHO International Standard (NIBSC code 91/510).
< 0.05 EU/µg using USP <85> / EP 2.6.14
Lyophilized vial is shipped at ambient temperature. Immediately upon receipt, store unopened vial at -20°C (manual defrost freezer) or -80°C for up to 36 months.
For ex vivo use only. Not for injection or diagnostic procedures. The safety and efficacy of this product in diagnostic or other clinical uses has not been established.